<Record>
<Term>Unoprostone Isopropyl</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Prostaglandin Compound</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Adjuvant/Anti-glaucoma Agent/Unoprostone Isopropyl,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Physiology-Regulatory Factor/Eicosanoid/Prostaglandin Compound/Unoprostone Isopropyl</ClassificationPath>
<BroaderTerm>Eicosanoid</BroaderTerm>
<BroaderTerm>Physiology-Regulatory Factor</BroaderTerm>
<BroaderTerm>Anti-glaucoma Agent</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Adjuvant</BroaderTerm>
<BroaderTerm>Unoprostone Isopropyl</BroaderTerm>
<BroaderTerm>Unoprostone Isopropyl,</BroaderTerm>
<BroaderTerm>Prostaglandin Compound</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>UNOPROSTONE ISOPROPYL</Synonym>
<Synonym>Unoprostone isopropyl</Synonym>
<Synonym>Rescula</Synonym>
<Synonym>Unoprostone Isopropyl</Synonym>
<Synonym>Isopropyl (+)-( Z )-7-[(1 R, 2 R, 3 R, 5 S )-3,5-dihydroxy-2-(3-oxodecyl) Cyclopentyl]-5-heptenoate</Synonym>
<Description>A docosanoid and a structural analogue of an inactive biosynthetic cyclic derivative of arachidonic acid, 13,14-dihydro-15-keto-prostaglandin F 2a. Although the mechanism of action is unknown, unoprostone isopropyl may reduce elevated intraocular pressure by increasing the outflow of aqueous humor upon ocular administration.</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
